ClinicalTrials.gg
RecruitingNCT07041502Aut-CAREUpdated Jun 27, 2025

Aut-CARE Intervention to Improve Cognitive and Emotional Functioning in Young Adults on the Autism Spectrum

An observational study in Autism Spectrum Disorder and Autism Spectrum Disorder With Absence of Functional Language, sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau. Recruiting at 1 site in Spain. Open to participants aged 16 Years to 30 Years. Per ClinicalTrials.gov, last updated 2025-06-27.

Sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Observational

How we know

From the registry’s dates

  • Started Oct 2024; still recruiting 2 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
37
Ages
16 Years to 30 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 32 studies in Autism Spectrum Disorder with a site in Spain — 7 open to participants now, 9 under way, 2 of them phase 3. Autism Spectrum Disorder · Spain.

Started
2024
with 4 others
Observational
5 of 32
3 open now
Registered
30th of 32
by date
Lead sponsor
2 of 32
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Among the 32 studies in Autism Spectrum Disorder with a site in Spain, this one is one of 5 that started in 2024, is one of 5 observational ones, and was the 30th registered.

Autism Spectrum Disorder

1,733 studies on the registry are indexed under Autism Spectrum Disorder; 503 are open to participants now.

Browse Autism Spectrum Disorder studies →

Open to participants now

7 of the 32 studies in Autism Spectrum Disorder with a site in Spain are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 351 Autism Spectrum Disorder studies recruiting now, 48 (14%) set no upper age limit and 296 (84%) stop at 75 or younger; 301 take children under 18; 92 take healthy volunteers.

This study: 16 Years to 30 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 32 studies in Autism Spectrum Disorder with a site in Spain, or all of them as a file.
02

Study summary

Currently, many autistic youths struggle to adapt to academic programs or the workforce, often turning to third-sector organizations such as specialized associations and foundations. This may be due to factors such as emotional dysregulation and executive dysfunction, which interfere with their psychosocial adaptation abilities, leading to anxiety and depression. These challenges have a neurobiological basis tied to the unique complexities of the autistic brain, which experiences emotional and cognitive overload and lacks attentional filters. To address this issue, the emotional and executive functioning of autistic youths at the Friends Foundation will be assessed through objective and subjective assessments.

This data collection will serve as a foundation for conceptualizing and co-creating a more realistic affective-cognitive remediation program, integrating user perspectives (conceptualization of interventions for systematic implementation). The program aims to improve the socio-occupational and emotional adaptation difficulties that often contribute to mental health challenges within this underserved population. It is important to highlight that many existing programs focus on cognitive training and social skills, neglecting strategies for adaptation and emotional regulation. This project will stand out for its inclusive design, featuring a representative sample of both sexes, overcoming the usual limitation of male-centered approaches.

Read the detailed description

The mixed or hybrid sequential study design (quantitative → qualitative → quantitative) includes three parts:

A) Assessment of socio-occupational, neuropsychological, and psychological variables to establish relationships between the degree of impairment and socio-occupational integration. Quantitative study.

B) Focus groups to determine the contents of the intervention program, which will be co-created as the Aut-CARE program. Qualitative study.

C) Pilot study of the Aut-CARE program to evaluate its format, content, feasibility, and acceptability.

Individuals aged 16 to 30 years with an ASD diagnosis, levels 1 and 2. The calculated sample size is 37 subjects for sub-study A; the minimum sample size for the focus groups (sub-study B) is 14; and a maximum of 10 participants for the pilot study (sub-study C).

03

Conditions studied

  • Autism Spectrum Disorder
  • Autism Spectrum Disorder With Absence of Functional Language
04

Who can participate

Ages eligible
16 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Individuals (females and males) aged 16 to 30 years with an ASD diagnosis, levels 1 and 2

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Subjects aged 16 to 30 years (male, female, and non-binary)
  • Attending one or more services of the Friends Foundation (Prelaboral Friends, Laboral Friends, and EducaFriends).
  • Diagnosed with ASD (according to criteria), levels 1 or 2, and without intellectual disability (IQ > 80).

Exclusion criteria

Exclusion Criteria:

  • None
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
37 participants (estimated)
Patient registry
No

Interventions

  • OtherAut-CARE

    There is no intervention

06

What researchers measure

Primary outcomes

  1. Difficulties in emotion regulation scale (DERS)

    The DERS is a measure of emotional dysregulation. The raw scores range from 36 to 180. Higher scores mean more difficulties.

    Time frame: 1 day

  2. Battery of cognitive tests

    A set of neuropsychological tests is administered: Trail Making Test-A, Trail Making Test-B, Digit Symbol Substitution Test, Digit Span, Letter and Numbers, and Phonetic Fluency (PMR). Scores will be t-transformed (mean=50, SD=10), so high scores mean better performance.

    Time frame: 1 day

07

Study locations

1 of 1 sites recruiting
  • Fundació Institut de Recerca de lHospital de la Santa Creu i Sant Pau
    Barcelona, Catalonia 08041, Spain
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2024 (actual). Primary completion is estimated for Sep 2026, 22 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
May 30, 2025
First posted
Jun 27, 2025
StartActual
Oct 16, 2024
Primary completionEst.
Sep 15, 2026
CompletionEst.
Sep 15, 2026
Last update
Jun 27, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 27, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07041502
Responsible party
Sponsor
First posted
Jun 27, 2025
Start date
Oct 16, 2024
Primary completion
Sep 15, 2026 (estimated)
Completion
Sep 15, 2026 (estimated)
Last update
Jun 27, 2025

Study contacts

Alejandra Espinosa
Contact
AEspinosaG@santpau.cat
+34 93 553 78 13
Muriel Vicent-Gil, Dr
Contact
mvicent@santpau.cat
+34 93 553 78 38

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion